pristane has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoroso, S; Bliskovski, V; Fernandez, T; Jones, GM; Kim, SJ; Kovalchuk, A; Letterio, JJ; Potter, M; Sharpe, S; Wakefield, LM | 1 |
| Barati, M; Esmaeili, SA; Faridzadeh, A; Hoseini, S; Hoseinzadeh, A; Lavi Arab, F; Mahmoudi, A; Mahmoudi, M; Rezaeian, A; Rezaieyazdi, Z; Sadat Tabasi, N; Tavakol Afshari, J | 1 |
2 other study(ies) available for pristane and transforming growth factor beta
| Article | Year |
|---|---|
Disruption of transforming growth factor beta signaling by a novel ligand-dependent mechanism.
Topics: Animals; Autocrine Communication; Blotting, Western; Cell Membrane; DNA-Binding Proteins; Ligands; Mice; Plasmacytoma; Protein Binding; Protein Serine-Threonine Kinases; Protein Transport; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; RNA, Antisense; Signal Transduction; Smad2 Protein; Terpenes; Trans-Activators; Transforming Growth Factor beta | 2002 |
Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Topics: Animals; Cytokines; Lupus Erythematosus, Systemic; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta | 2023 |